$EBS Emergent BioSolutions Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Emergent BioSolutions Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Emergent BioSolutions Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Emergent BioSolutions Inc. for free.
IRS Number: 141902018
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: EBS
Company Address: 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG 20879
Phone number: 240-631-3200
Market Capitalization: $1.21B
Prev close: $29.35
Average Daily Volume: 498,308
Days Low: $28.81
Year Low: $24.47
Year High: $44.38
Emergent BioSolutions Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11 2021 | EBS | Emergent BioSoluti ... | LINDAHL RICHARD S | EVP, Chief Financia ... | Payment of Exercise | F | 61.62 | 1,054 | 64,947 | 36,919 | 38 K to 36.9 K (-2.78 %) |
| May 11 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 61.62 | 94 | 5,792 | 163,053 | 163.1 K to 163.1 K (-0.06 %) |
| May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 18.64 | 10,305 | 192,085 | 0 | |
| May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 61.62 | 3,118 | 192,131 | 39,945 | 43.1 K to 39.9 K (-7.24 %) |
| May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 18.64 | 10,305 | 192,085 | 43,063 | 32.8 K to 43.1 K (+31.46 %) |
| Apr 01 2021 | EBS | Emergent BioSoluti ... | Kirk Sean | EVP, Manufacturing ... | Payment of Exercise | F | 0.00 | 159 | 0 | 17,776 | 17.9 K to 17.8 K (-0.89 %) |
| Mar 08 2021 | EBS | Emergent BioSoluti ... | Bailey Sue | Director | Sell | S | 92.37 | 8,168 | 754,478 | 24,427 | 32.6 K to 24.4 K (-25.06 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 0.00 | 13,906 | 0 | 13,906 | |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | El-Hibri Fuad | Chairman | Option Exercise | A | 93.49 | 27,808 | 2,599,770 | 27,808 | |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Option Exercise | A | 93.49 | 59,898 | 5,599,864 | 59,898 | |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 97.15 | 860 | 83,549 | 163,147 | 164 K to 163.1 K (-0.52 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 97.15 | 1,716 | 166,709 | 164,007 | 165.7 K to 164 K (-1.04 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Payment of Exercise | F | 93.49 | 2,425 | 226,713 | 165,723 | 168.1 K to 165.7 K (-1.44 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 14,975 | 0 | 168,148 | 153.2 K to 168.1 K (+9.78 %) |
| Feb 26 2021 | EBS | Emergent BioSoluti ... | Kramer Robert | President and CEO | Grant | A | 0.00 | 14,975 | 0 | 153,173 | 138.2 K to 153.2 K (+10.84 %) |